TrialTargeted oncology2025

A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid Tumors.

Cathy Eng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.